Original StudyThe Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents
Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy causing anovulatory infertility, and it affects approximately 5% of women of reproductive age.1 The clinical spectrum of PCOS includes hyperandrogenism, menstrual irregularities, and infertility.2 Rotterdam consensus criteria (2 of the 3 following criteria: oligo or anovulation, clinical or biochemical signs of hyperandrogenism, and polycystic ovaries) are used to diagnose PCOS.3 PCOS might be a proinflammatory state related to inflammation at the molecular level and insulin resistance.4, 5
The extracellular cysteine protease inhibitor, cystatin C, belongs to the cystatin superfamily and consists of 122 amino acids. It is a basic, low molecular weight, cationic protein, known for its involvement in intracellular protein catabolism. Recent studies have shown that cystatin C is not only a more sensitive indicator of renal function but also a strong independent predictor of cardiovascular disease, diabetes, and all-cause mortality.6, 7 Cystatin is related to low-intensity inflammation and tumor metastasis.8
In this prospective case-control study, we evaluated the association between the clinical parameters of PCOS and serum cystatin levels in adolescents, to examine a possible inflammatory pathogenesis.
Section snippets
Ethics Statement
This study was approved by the Ethics Committee of Ankara Zekai Tahir Burak Women's Health Research and Education Hospital. Informed consent was obtained from each participant before enrolling in the study.
Study Population and Design
In this prospective case-control study we enrolled 89 adolescents seen between January 1, 2014 and December 31, 2015 at the outpatient adolescence clinic of Ankara Zekai Tahir Burak Women's Health Research and Education Hospital, a tertiary referral hospital, and a group of 84 healthy control
Results
In Table 1 the demographic, clinical, and laboratory findings of the subjects are summarized. Patients with PCOS had significantly higher BMI, WHR, and FGS compared with the control participants (P < .05). The triglyceride and LDL cholesterol levels were higher and the HDL cholesterol levels were lower in the PCOS patients (P < .05). The HOMA-IR index scores and DHEA-S, hs-CRP, free testosterone, and cystatin C levels were significantly higher in the study group (P < .05).
Correlation analysis
Discussion
In this study we evaluated the possible association between inflammation and the pathogenesis of PCOS. To our knowledge, this is the first study to evaluate the association between adolescent PCOS and the proinflammatory marker cystatin C. The clinical parameters evaluated were age, BMI, WHR, FGS, triglyceride, total cholesterol, HDL, LDL, hs-CRP, cystatin C, follicle-stimulating hormone, LH, estradiol, HOMA-IR, DHEA-S, free testosterone, and progesterone levels.
The BMI, WHR and FGS,
References (21)
- et al.
Is serum cystatin-C a reliable marker for metabolic syndrome?
Am J Med
(2008) - et al.
Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases
Int J Cardiol
(2012) - et al.
Cystatin C reference values and aging
Clin Biochem
(2006) - et al.
Polycystic ovary syndrome: syndrome XX?
Trends Endocrinol Metab
(2003) - et al.
PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Eur J Obstet Gynecol Reprod Biol
(2005) - et al.
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
Endocr Rev
(1995) Polycystic ovary syndrome
N Engl J Med
(1995)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
Fertil Steril
(2004)- et al.
In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome
J Endocrinol
(2006) - et al.
Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome
J Clin Endocrinol Metab
(2006)
Cited by (9)
Role of cystatin C levels as an inflammatory marker in predicting endometriosis
2023, Revista da Associacao Medica BrasileiraPolycystic Ovary Syndrome in Adolescence: Challenges in Diagnosis and Management
2022, Revista Brasileira de Ginecologia e ObstetriciaThe role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome
2022, Turkish Journal of Obstetrics and GynecologyThe role of chronic inflammation in polycystic ovarian syndrome—a systematic review and meta-analysis
2021, International Journal of Molecular SciencesCardiometabolic risk factors in adolescents with polycystic ovary syndrome
2021, Current Pharmaceutical Design
The authors indicate no conflicts of interest.